StockKit ResearchEQUITY RESEARCH BRIEF
LLY · US · Fresh
Generated 2026-09-12 14:23 UTC
LLY
LLY · US
$1,197.53
+0.13%
Technical posture
Constructive
Strategy score
65 / 100
Trend
bull
Data confidence
High
Research view
LLY Research Preview
1. Bottom line
- LLY (LLY) is trading at 1197.53, with a current daily move of +0.13%.
- The StockKit strategy score is 65/100, creating a neutral research posture with bullish alignment (ma5 > ma10 > ma20 > ma60).
- The most important near-term watch zone is support at 1118.27 and resistance at 1245.75; price is +6.62% from support and +4.03% from resistance.
2. Key data snapshot
| Item | Reading | Interpretation |
|---|---:|---|
| Current price | 1197.53 | Daily move +0.13% |
| Strategy score | 65/100 | Buy, trend: bull |
| MA structure | Bullish alignment (MA5 > MA10 > MA20 > MA60) | The short-term moving average is above the medium-term moving average, which points to a firmer near-term structure. |
| RSI14 | 50.06 | Neutral momentum |
| MACD | 1.37 histogram | Bullish MACD configuration |
| Support / resistance | 1118.27 / 1245.75 | Watch these levels for confirmation or failure |
| 30-session range | 1109.15 / 1249.45 | Price sits at +62.99% of the range |
| Volume check | -14.68% vs 20D avg | Confirmation quality depends on volume follow-through |
| ATR14 / price | +3.71% | Proxy for short-term volatility risk |
3. Technical indicator panel
- Trend: The short-term moving average is above the medium-term moving average, which points to a firmer near-term structure.
- Momentum: RSI14 is not giving an extreme signal, so confirmation from price structure matters more than momentum alone.
- MACD: histogram is 1.37, while MACD line / signal are 10.71 / 9.34.
- KDJ: K / D / J are 69.13 / 68.71 / 69.96; KDJ constructive crossover.
- Bollinger: Mid-band zone (62% of band); upper / middle / lower are 1245.75 / 1182.01 / 1118.27.
- ATR / OBV / CCI: ATR14 is 43.74 (+3.71% of price), OBV slope is -87.99%, and CCI20 is 2.82.
- Levels: estimated support / resistance are 1118.27 / 1245.75; recent 30-session range is 1109.15 / 1249.45.
4. Valuation matrix
| Axis | Reading | Source | Confidence |
|---|---|---|---|
| PE | 52.18 | SEC EDGAR companyfacts | Medium |
| PB | 31.79 | SEC EDGAR companyfacts | Medium |
| Price / sales | 16.52 | SEC EDGAR companyfacts | Medium |
| EV/EBITDA | 559.27 | SEC EDGAR companyfacts | Low |
| PEG proxy | 2.90 | StockKit scenario model | Medium |
| StockKit fair value range | Bear $460.15 / Base $632.81 / Bull $795.08 | StockKit DCF scenario model | Medium |
| Base fair-value gap | -47.2% | StockKit DCF scenario model | Medium |
| 5Y growth forecast | Bear +10.00% / Base +18.00% / Bull +24.00% | StockKit scenario model | Medium |
| Revenue | $65.18B | SEC EDGAR companyfacts | High |
| Net income | $20.64B | SEC EDGAR companyfacts | High |
| Market cap | $1.08T | SEC shares outstanding + live quote | Medium |
| Balance sheet context | Assets $142.28B / Equity $33.88B | SEC EDGAR companyfacts | High |
Notes: - SEC CIK: 0000059478; company: ELI LILLY & Co. - Latest annual income-statement period used where available: 2025-12-31. - PEG and fair-value range are StockKit scenario outputs computed from reported fundamentals; they are not analyst consensus targets.
5. News and catalyst timeline
1. Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions - PRNewswire
2. Eli Lilly Stock Has Become a Trillion-Dollar Giant. Is It Too Late to Buy? - Biztoc.com
3. What Eli Lilly Was Telling You While It Rationed Its Own Launches - Trefis
4. Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks - Yahoo Entertainment
6. Sentiment radar
5 recent headlines available; no provider-level sentiment score was supplied.
| Source | Status | Reading | Confidence |
|---|---|---|---|
| NewsAPI headline coverage | 5 headlines | Biztoc.com x2, PRNewswire x1, Trefis x1 | Medium |
| Social sentiment | Not connected | No social sentiment conclusion is drawn | Low |
Notes: - No provider sentiment series was returned for this symbol.
7. Scenario framework
| Scenario | Trigger condition | Confirmation signal | Invalidation signal |
|---|---|---|---|
| Base case | Price remains between 1118.27 and 1245.75 | Strategy score stays near 65/100 and RSI avoids extremes | Close below support or a rapid score deterioration |
| Upside case | Price clears 1245.75 | Improving MACD histogram and volume above 20D average | Failed breakout back below resistance |
| Downside case | Price breaks 1118.27 | RSI weakens and MACD remains negative | Quick recovery back above support |
8. Risk matrix
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Technical failure | Support at 1118.27 anchors the current setup | Close below support | Reassess trend and reduce confidence in base case |
| Momentum exhaustion | Neutral momentum; MACD state: Bullish MACD configuration | RSI extension or MACD rollover | Watch next 1-3 closes and histogram direction |
| Volatility expansion | ATR14 / price is +3.71% | Wide ranges without follow-through | Require confirmation before trusting a directional move |
| News/data gap | 5 current news items available | New headline or missing catalyst context | Refresh news before relying on stale views |
9. Seven-day watch checklist
- First watch: whether price respects 1118.27 or starts accepting below it.
- Breakout watch: whether price can clear 1245.75 with volume confirmation above the 20-session average.
- Momentum watch: whether RSI14 stays constructive without moving into an exhaustion zone.
- Risk watch: whether fresh news changes the catalyst picture.
Strategy cross-check
| Strategy | Score | Signal | Basis |
|---|---|---|---|
| MA交叉 | 90/100 | StrongBuy | MA5>MA20金叉，多头排列 |
| MACD背离 | 70/100 | Buy | MACD金叉，MACD在零轴上方，动能减弱 |
| RSI极值 | 50/100 | Hold | RSI14=50中性 |
| 布林带 | 55/100 | Hold | 在通道中部，带宽扩张中 |
Information-use note
StockKit provides market research tools for informational and educational use. The output does not constitute personalized investment advice or a recommendation to buy, sell, or hold any security.
Strategy factors
MA交叉Strong momentum
90
MA5>MA20金叉，多头排列
MACD背离Constructive
70
MACD金叉，MACD在零轴上方，动能减弱
RSI极值Neutral
50
RSI14=50中性
布林带Neutral
55
在通道中部，带宽扩张中
量价关系Neutral
55
缩量回调，可能企稳
News & catalyst inputs
Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
PRNewswire · 2026-09-11
Eli Lilly Stock Has Become a Trillion-Dollar Giant. Is It Too Late to Buy?
Biztoc.com · 2026-09-10
What Eli Lilly Was Telling You While It Rationed Its Own Launches
Trefis · 2026-09-09
Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks
Yahoo Entertainment · 2026-09-09
Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031
Biztoc.com · 2026-09-09
Research boundary
StockKit organizes market data and model output for research workflows. It does not provide personalized advice or trade instructions. Verify important information with primary sources before any investment decision.
Disclaimer.This brief is generated by StockKit AI from public market data and algorithmic models for informational research only. It is not investment advice, an offer, or a solicitation, and it does not provide buy, sell, or hold ratings, price targets, stop-loss levels, or position sizing. “Watch levels” and “scenarios” describe observable conditions in the supplied data, not instructions. Verify all information with primary sources before any investment decision.